Cooper Companies | COO - Srodki Pieniężne I Ekwiwalent

Cena Akcji
71.21
Dzienna Zmiana
-0.25 -0.35%
Miesięcznie
-3.44%
Rocznie
-8.07%
Q2 Prognozy TE
68.06




Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 8.52B 1.01B 2025-12
Align Technology USD 1B 103.43M 2025-09
AtriCure USD 167.43M 19.56M 2025-12
Avanos Medical USD 89.8M 19.3M 2025-12
Bausch Health Companies USD 1.31B 419M 2025-09
Baxter International USD 1.97B 240M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dentsply International USD 326M 37M 2025-12
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Globus Medical USD 526.16M 154.39M 2025-12
Haemonetics USD 363.37M 66.94M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
J&J USD 19.71B 1.48B 2025-12
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Novartis USD 9.56B 2.9B 2025-09
ResMed USD 1.42B 33.22M 2025-12
STAAR Surgical USD 153.15M 23M 2025-12
Steris USD 423.7M 104.5M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Utah Medical Products USD 84.27M 2.09M 2025-09
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12